Published Online: March 20, 2013. doi:10.1001/jamadermatol.2013.2766
Accepted for Publication: November 19, 2012.
Author Contributions: Dr Lebwohl had full access to all the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis. Study concept and design: Lebwohl. Acquisition of data: Lebwohl, Shumack, Stein Gold, and Tyring. Analysis and interpretation of data: Lebwohl, Shumack, Stein Gold, Melgaard, Larsson, and Tyring. Drafting of the manuscript: Lebwohl, Shumack, Stein Gold, Melgaard, and Tyring. Critical revision of the manuscript for important intellectual content: Lebwohl, Shumack, Stein Gold, Melgaard, Larsson, and Tyring. Obtained funding: Larsson. Administrative, technical, or material support: Melgaard and Larsson.
Conflict of Interest Disclosures: Dr Lebwohl has been a consultant and investigator for Graceway/Medicis and for LEO Pharma. Dr Shumack is on an advisory board for and has been an investigator and speaker for LEO Pharma. Dr Stein Gold is a consultant, investigator, and speaker and sits on an advisory board for LEO Pharma. Ms Melgaard and Dr Larsson are employees of LEO Pharma. Dr Tyring has been an investigator for LEO Pharma.
Funding/Support: This research was supported by LEO Pharma.
Role of the Sponsor: LEO Pharma was involved in the design and conduct of the studies; the collection, management, analysis, and interpretation of the data; and the preparation, review, and approval of the manuscript.
Additional Contributions: Janice S. Drew, BSc, MPH, contributed to data preparation and analysis. J. Michael White, PhD, reviewed and performed integrated analyses from reports of statistical analyses by TKL Research, Inc. ProHealth assisted with preparation of the manuscript for submission.